1,464.50p-93.57 (-5.98%)29 Jul 2021, 17:19
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Smith & Nephew PLC Fundamentals

Company NameSmith & Nephew PLCLast Updated2021-07-29
IndustryMedical DevicesSectorHealthcare
Shares in Issue879.140 mMarket Cap£12.92 bn
PE Ratio41.15Dividend per Share$0.37
Dividend Yield1.82Dividend Cover1.37
EPS$0.51EPS Growth (%)-0.20
PEG0.87DPS Growth (%)0.0283
Debt Ratio0.3351Debt Equity Ratio0.6352
Asset Equity Ratio2.0860Cash Equity Ratio0.3338
Quick Ratio1.6428Current Ratio2.76
Price To Book Value3.6140ROCE0

Smith & Nephew PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Smith & Nephew PLC Company Financials

Tangible Assets$1.45 bn$1.32 bn$1.06 bn
Intangible Assets$4.41 bn$4.36 bn$3.55 bn
Investments$117.00 m$110.00 m$139.00 m
Total Fixed Assets$6.35 bn$6.08 bn$4.98 bn
Stocks$1.69 bn$1.61 bn$1.40 bn
Debtors$1.01 bn$1.21 bn$1.28 bn
Cash & Equivalents$1.76 bn$277.00 m$365.00 m
Other Assets000
Total Assets$11.01 bn$9.30 bn$8.06 bn
Creditors within 1 year$1.69 bn$1.56 bn$1.47 bn
Creditors after 1 year$4.04 bn$2.59 bn$1.72 bn
Other Liabilities000
Total Liabilities$5.73 bn$4.16 bn$3.19 bn
Net assets$5.28 bn$5.14 bn$4.87 bn
Called up share capital$177.00 m$177.00 m$177.00 m
Share Premium$630.00 m$628.00 m$626.00 m
Profit / Loss$246.00 m$743.00 m$781.00 m
Other Equity$5.28 bn$5.14 bn$4.87 bn
Preference & Minorities000
Total Capital Employed$5.28 bn$5.14 bn$4.87 bn
Debt Ratio$0.39$0.28$0.21
Assets / Equity2.08602.08602.0860
Cash / Equity0.33380.33380.3338
Cash Flow202020192018
Cash from operating activities$935.00 m$1.17 bn$931.00 m
Cashflow before financing$2.10 bn$1.18 bn$560.00 m
Increase in Cash$1.49 bn-$76.00 m$182.00 m
Turnover$4.56 bn$5.14 bn$4.90 bn
Cost of sales$1.40 bn$1.34 bn$1.30 bn
Gross Profit$3.16 bn$3.80 bn$3.61 bn
Operating Profit$295.00 m$815.00 m$863.00 m
Pre-Tax profit$246.00 m$743.00 m$781.00 m

Smith & Nephew PLC Company Background

ActivitiesSmith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Latest Interim Date29 Jul 2021
Latest Fiscal Year End Date18 Feb 2021

Smith & Nephew PLC Directors

2018-04-12Mr. Joseph C. PapaIndependent Director
2021-03-01Mr. Marc E. OwenNon-Executive Director
2019-04-11Dr. Michael A. Friedman M.D.Non-Executive Director
2018-05-07Mr. Olivier BohuonDirector and Chief Executive Officer
2014-07-31Dr. Pamela Josephine Kirby Non-Executive Director
2007-02-15Mr. Warren Decatur KnowltonNon-Executive Director
2012-12-31Mr. Adrian Nevil Hennah Executive Director,Chief Financial Officer
2017-04-06Mr. Brian Paul LarcombeIndependent Non-Executive Director
2012-03-01Mr. David J. IllingworthExecutive Director,Chief Executive Officer
2021-03-01Mr. Erik EngstromNon-Executive Director
2014-04-10Mr. Richard Urbain de SchutterNon-Executive Director
2021-03-01Mr. Robin A D FreestoneNon-Executive Director,Senior Independent Non-Executive Director
2004-12-16Dr. Rolf Wilhelm Heinrich StombergNon-Executive Director
2011-08-09Sir Christopher John O'Donnell Executive Director
2019-04-11Mr. Ian E. BarlowNon-Executive Director
2021-03-01Mr. Roberto QuartaNon-Executive Director,Chairman
2014-04-10Sir John BuchananNon-Executive Director,Chairman
2021-03-01Mr. Charles Richard MedlockNon-Executive Director
2021-03-01Ms. Angie RisleyNon-Executive Director
2012-11-01Professor Genevieve BergerNon-Executive Director
2021-04-14The Right Honourable Baroness Virginia Bottomley of Nettlestone, PC DLNon-Executive Director
2014-03-24Mr. Ajay G PiramalNon-Executive Director
2018-03-05Ms. Julie BrownExecutive Director,Chief Financial Officer
2019-10-31Mr. Namal Nawana Executive Director,Chief Executive Officer
2021-05-21Ms. Anne-Francoise NesmesExecutive Director,Chief Financial Officer
2021-03-01Ms. Vinita BaliNon-Executive Director
2020-04-09Mr. Graham Timothy Baker Executive Director,Chief Financial Officer
2021-03-01Mr. Robert J. WhiteNon-Executive Director
2021-05-21Mr. Roland Daniel Diggelmann Executive Director,Chief Executive Officer

Smith & Nephew PLC Contact Details

Company NameSmith & Nephew PLC
AddressHatters Lane, Building 5, Croxley Park, Watford, WD18 8YE
Telephone+44 1923477100

Smith & Nephew PLC Advisors

RegistrarComputershare Investor Services PLC
Phone+44 3707020003
Fax+44 3707036101
Phone+44 2073111000
Fax+44 2073113311
StockbrokerBank of America Merrill Lynch
Phone+44 2076281000
Fax+44 2078672867
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
BankNational Westminster Bank PLC
StockbrokerJ.P. Morgan Cazenove Ltd
Phone+44 2077424000
BankLloyds Bank PLC
Remuneration ConsultantWillis Towers Watson
Phone+44 2071702000
Fax+44 2071702222
SolicitorAshurst LLP
Phone+44 2076381111
Fax+44 2076381112
SolicitorFreshfields Bruckhaus Deringer
Phone+44 2079364000
Fax+44 2078327001
SolicitorPinsent Masons LLP
Phone+44 2074187000
Fax+44 2074187050
SolicitorSquire Patton Boggs
Phone+44 2076551000
Fax+44 2076551001
BankChase Manhattan Bank N.A. (The)
AuditorErnst & Young LLP